Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced that Chief Executive Officer Ted Myles will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback